Val66Met polymorphism and serum brain-derived neurotrophic factor concentration in depressed patients

Acta Neuropsychiatrica

Volumn 23, Issue 5, 2011, Pages 229-234

  Zhang, Xiao Bin ^a   Wang, Xin ^b   Sha, Wei Wei ^a   Zhou, Hong Hui ^a   Zhang, Yu Mei ^a  

^a YANGZHOU UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

brain derived neurotrophic factor; genotype; major depressive disorder; serum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED INTERVIEW;

EID: 80052963668     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2011.00560.x     Document Type: Conference Paper

References (42)

1. Huang EJ, Reichardt LF., Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736. (Pubitemid 32695243)
2. Brunoni AR, Lopes M, Fregni F., A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008; 11: 1169-1180.
3. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP., Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 2001; 120: 87-95. (Pubitemid 32118151)
4. Smith MA, Makino S, Kvetnansky R, Post RM., Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995; 15: 1768-1777.
5. Schmidt HD, Duman RS., The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 2007; 18: 391-418. (Pubitemid 47356367)
6. Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS., Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 2009; 30: 3719-3735.
7. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM., Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131-137. (Pubitemid 27016116)
8. Altar CA, Whitehead RE, Chen R, Wörtwein G, Madsen TM., Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 2003; 54: 703-709. (Pubitemid 37281386)
9. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT., Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 60-265.
10. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN., Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60: 804-815. (Pubitemid 36960912)
11. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G., Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57: 1068-1072. (Pubitemid 40613035)
12. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S., Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005; 255: 381-386. (Pubitemid 43029827)
13. Sen S, Duman R, Sanacora G., Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analysis and implications. Biol Psychiatry 2008; 64: 527-532.
14. Rybakowski JK., BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 2008; 9: 1589-1593.
15. Schumacher J, Jamra RA, Becker T, et al., Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005; 58: 307-314. (Pubitemid 41133624)
16. Lang UE, Hellweg R, Sander T, Gallinat J., The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 2009; 14: 120-122.
17. Ozan E, Okur H, Eker C, Eker OD, Gönül AS, Akarsu N., The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 2010; 81: 61-65.
18. Jiang H, Wang R, Liu Y, Zhang Y, Chen ZY., BDNF Val66Met polymorphism is associated with unstable angina. Clin Chim Acta 2009; 400: 3-7.
19. Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM., Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull 2007; 73: 143-149. (Pubitemid 46722657)
20. Tramontina J, Frey BN, Andreazza AC, Zandona M, Santin A, Kapczinski F., Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol Psychiatry 2007; 12: 230-231. (Pubitemid 46328510)
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
22. First MB, Spitzer RL, Gibbon M, Williams JB., Structured clinical interview for DSM-IV (SCID-I). New York: Biomedics Research Department, 1998.
23. Hamilton M., A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
24. Bagby RM, Ryder AG, Schuller DR, MarshaIl MB., The Hamilton Depression Rating Scale: Has the Gold Standard become a lead weight? Am J Psychiatry 2004; 161: 2163-2177. (Pubitemid 39587278)
25. Maier W, Philipp M., Improving the assessment of severity of depressive states: a reduction of the Hamilton Depression Scale. Pharmacopsychiatry 1985; 18: 114-115. (Pubitemid 15137667)
26. Lee BH, Kim YK., Reduced platelet BDNF level in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 849-853.
27. Bocchio-Chiavetto L, Bagnardi V, Zanardini R, et al., Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry 2010; 11: 763-773.
28. Shimizu E, Hashimoto K, Okamura N, et al., Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-75. (Pubitemid 36776725)
29. Lee BH, Kim H, Park SH, Kim YK., Decreased plasma BDNF level in depressive patients. J Affect Disord 2007; 101: 239-244. (Pubitemid 46879923)
30. Bus BA, Molendijk ML, Penninx BJ, et al., Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011; 36: 228-239.
31. Huang TL, Lee CT, Liu YL., Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res 2008; 42: 521-525.
32. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ., Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 186-189.
33. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ., Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet 2003; 123B: 19-22. (Pubitemid 37323258)
34. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM., The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2006; 27: 1834-1837.
35. Zou YF, Ye DQ, Feng XL, Su H, Pan FM, Liao FF., Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. Eur Neuropsychopharmacol 2010; 20: 535-544.
36. Kato M, Serretti A., Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry 2010; 15: 473-500.
37. Domschke K, Lawford B, Laje G, et al., Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol 2010; 13: 93-101.
38. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vásquez A, Buitelaar JK, Franke B., Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 2010; 15: 260-271.
39. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, Hempstead BL, Lee FS., Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24: 4401-4411. (Pubitemid 38608151)
40. Egan MF, Kojima M, Callicott JH, et al., The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269. (Pubitemid 36144114)
41. Chen ZY, Jing D, Bath KG, et al., Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006; 314: 140-143. (Pubitemid 44547760)
42. Terracciano A, Martin B, Ansari D, et al., Plasma BDNF concentration, Val66Met genetic variant and depression-related personality traits. Genes Brain Behav 2010; 9: 512-518.